{"id":55712,"date":"2026-01-28T20:49:40","date_gmt":"2026-01-28T12:49:40","guid":{"rendered":"https:\/\/flcube.com\/?p=55712"},"modified":"2026-01-28T20:49:42","modified_gmt":"2026-01-28T12:49:42","slug":"china-drug-administration-implementation-regulations-set-for-may-2026-launch","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=55712","title":{"rendered":"China Drug Administration Implementation Regulations Set for May 2026 Launch"},"content":{"rendered":"\n<p>China\u2019s <strong>State Council<\/strong> this week issued the <strong>Implementation Regulations of the Drug Administration Law<\/strong>, a comprehensive 89\u2011article framework taking effect on <strong>May\u202f15\u202f2026<\/strong>. The regulations establish stricter oversight across the drug lifecycle while accelerating pathways for innovation, data protection, and pediatric and rare disease therapies.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-regulatory-framework-overview\">Regulatory Framework Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Effective Date<\/strong><\/td><td>May\u202f15\u202f2026<\/td><\/tr><tr><td><strong>Structure<\/strong><\/td><td>89 articles across nine chapters<\/td><\/tr><tr><td><strong>Core Principles<\/strong><\/td><td>People\u2011centered, scientific, ethical, comprehensive risk prevention<\/td><\/tr><tr><td><strong>Key Focus Areas<\/strong><\/td><td>Innovation support, certificate management, accelerated approval, data protection<\/td><\/tr><tr><td><strong>State Priorities<\/strong><\/td><td>New drug R&amp;D, traditional Chinese medicine (TCM) innovation, generic drug quality improvement<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-key-policy-provisions\">Key Policy Provisions<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-innovation-amp-approval-acceleration\"><strong>Innovation &amp; Approval Acceleration<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Four Expedited Pathways:<\/strong> Breakthrough Therapy Designation, Conditional Approval, Priority Review, and Special Approval for eligible applications<\/li>\n\n\n\n<li><strong>Overseas Data:<\/strong> Research data obtained abroad may be used for registration if compliant with Chinese regulations<\/li>\n\n\n\n<li><strong>TCM Promotion:<\/strong> State will advance TCM inheritance and innovation, leveraging its role in prevention and healthcare<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-certificate-validity-amp-renewal\"><strong>Certificate Validity &amp; Renewal<\/strong><\/h3>\n\n\n\n<p>All major drug\u2011related certificates are valid for <strong>five years<\/strong>, including:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Drug Non\u2011clinical Safety Evaluation Research Institution Qualification Certificate<\/li>\n\n\n\n<li>Drug Registration Certificate<\/li>\n\n\n\n<li>Drug Manufacturing License<\/li>\n\n\n\n<li>Drug Distribution License<\/li>\n\n\n\n<li>Chemical API Approval Certificate<\/li>\n\n\n\n<li>Medical Institution Preparation Permit<\/li>\n<\/ul>\n\n\n\n<p><strong>Medical Institution Preparation Registration Certificate:<\/strong> Valid for <strong>three years<\/strong><br>All certificates require renewal upon expiration.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-market-exclusivity-amp-data-protection\"><strong>Market Exclusivity &amp; Data Protection<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Pediatric Drugs:<\/strong> Up to <strong>2\u2011year market exclusivity<\/strong> for new pediatric varieties, dosage forms, or indications meeting certain conditions<\/li>\n\n\n\n<li><strong>Rare Disease Drugs:<\/strong> Up to <strong>7\u2011year market exclusivity<\/strong> for eligible products, provided marketing authorization holder ensures supply (failure results in termination)<\/li>\n\n\n\n<li><strong>Data Protection:<\/strong> Drugs with new chemical components receive up to <strong>6\u202fyears<\/strong> protection for undisclosed clinical and other data<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-manufacturing-restrictions-amp-exceptions\"><strong>Manufacturing Restrictions &amp; Exceptions<\/strong><\/h3>\n\n\n\n<p><strong>Prohibited from delegated production:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Blood products, narcotic drugs, psychotropic substances, medicinal toxic drugs, drug manufacturing precursors, and combination products containing these substances<\/li>\n<\/ul>\n\n\n\n<p><strong>Allowed segmented delegated production<\/strong> (with unified quality assurance) for:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Drugs with special production processes<\/li>\n\n\n\n<li>Clinically urgent drugs<\/li>\n\n\n\n<li>Multivalent\/multicomponent vaccines<\/li>\n<\/ul>\n\n\n\n<p><strong>Pre\u2011approval commercial batches<\/strong> (for new drugs, rare disease drugs, shortage drugs, and other urgent therapies) may be marketed if produced before obtaining approval documents and passing GMP inspections, provided they meet release requirements.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-online-sales-prohibition\"><strong>Online Sales Prohibition<\/strong><\/h3>\n\n\n\n<p><strong>Prohibited from online sales:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Vaccines, blood products, narcotic drugs, psychotropic substances, medicinal toxic drugs, radioactive pharmaceuticals, and drug manufacturing precursors<\/li>\n\n\n\n<li>Other high\u2011risk drugs as specified by the State Council drug regulatory department<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-clinical-import-pathway\"><strong>Clinical Import Pathway<\/strong><\/h3>\n\n\n\n<p>Medical institutions may apply to import small quantities of clinically urgent drugs; applications will be reviewed by the national drug regulatory department or authorized provincial governments.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact-amp-strategic-implications\">Market Impact &amp; Strategic Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Innovation Incentive:<\/strong> Expanded exclusivity and data protection strengthen IP rights, encouraging <strong>\u00a5100\u202fbillion+<\/strong> annual R&amp;D investment by domestic pharma<\/li>\n\n\n\n<li><strong>Manufacturing Flexibility:<\/strong> Segmented production rules enable <strong>CDMO growth<\/strong>, particularly for complex biologics and vaccines<\/li>\n\n\n\n<li><strong>Online Pharmacy Constraints:<\/strong> Further restrictions on controlled substances reinforce <strong>offline distribution<\/strong> dominance; high\u2011risk drug lists will be closely watched by e\u2011pharmacy platforms<\/li>\n\n\n\n<li><strong>Import Acceleration:<\/strong> Streamlined urgent import pathway benefits <strong>rare disease<\/strong> and <strong>oncology<\/strong> patients needing immediate access to foreign drugs<\/li>\n\n\n\n<li><strong>Compliance Burden:<\/strong> Five\u2011year renewal cycle increases administrative workload; companies must prepare for <strong>2027 renewal wave<\/strong><\/li>\n\n\n\n<li><strong>Next Steps:<\/strong> Provincial drug regulators will issue implementation guidelines by <strong>Q2\u202f2026<\/strong>; industry associations conducting compliance training throughout 2026<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding regulatory implementation timelines, market impacts, and industry adaptation to the new Drug Administration Law Implementation Regulations. Actual outcomes may differ due to regulatory interpretation, enforcement inconsistencies, and industry lobbying efforts.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China\u2019s State Council this week issued the Implementation Regulations of the Drug Administration Law, a&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[59],"class_list":["post-55712","post","type-post","status-publish","format-standard","hentry","category-policy-regulatory","tag-state-council"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>China Drug Administration Implementation Regulations Set for May 2026 Launch - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China\u2019s State Council this week issued the Implementation Regulations of the Drug Administration Law, a comprehensive 89\u2011article framework taking effect on May\u202f15\u202f2026. The regulations establish stricter oversight across the drug lifecycle while accelerating pathways for innovation, data protection, and pediatric and rare disease therapies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=55712\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China Drug Administration Implementation Regulations Set for May 2026 Launch\" \/>\n<meta property=\"og:description\" content=\"China\u2019s State Council this week issued the Implementation Regulations of the Drug Administration Law, a comprehensive 89\u2011article framework taking effect on May\u202f15\u202f2026. The regulations establish stricter oversight across the drug lifecycle while accelerating pathways for innovation, data protection, and pediatric and rare disease therapies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=55712\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-28T12:49:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-28T12:49:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55712#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55712\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"China Drug Administration Implementation Regulations Set for May 2026 Launch\",\"datePublished\":\"2026-01-28T12:49:40+00:00\",\"dateModified\":\"2026-01-28T12:49:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55712\"},\"wordCount\":578,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"State Council\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55712#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55712\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=55712\",\"name\":\"China Drug Administration Implementation Regulations Set for May 2026 Launch - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-01-28T12:49:40+00:00\",\"dateModified\":\"2026-01-28T12:49:42+00:00\",\"description\":\"China\u2019s State Council this week issued the Implementation Regulations of the Drug Administration Law, a comprehensive 89\u2011article framework taking effect on May\u202f15\u202f2026. The regulations establish stricter oversight across the drug lifecycle while accelerating pathways for innovation, data protection, and pediatric and rare disease therapies.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55712#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55712\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55712#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China Drug Administration Implementation Regulations Set for May 2026 Launch\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"China Drug Administration Implementation Regulations Set for May 2026 Launch - Insight, China&#039;s Pharmaceutical Industry","description":"China\u2019s State Council this week issued the Implementation Regulations of the Drug Administration Law, a comprehensive 89\u2011article framework taking effect on May\u202f15\u202f2026. The regulations establish stricter oversight across the drug lifecycle while accelerating pathways for innovation, data protection, and pediatric and rare disease therapies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=55712","og_locale":"en_US","og_type":"article","og_title":"China Drug Administration Implementation Regulations Set for May 2026 Launch","og_description":"China\u2019s State Council this week issued the Implementation Regulations of the Drug Administration Law, a comprehensive 89\u2011article framework taking effect on May\u202f15\u202f2026. The regulations establish stricter oversight across the drug lifecycle while accelerating pathways for innovation, data protection, and pediatric and rare disease therapies.","og_url":"https:\/\/flcube.com\/?p=55712","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-28T12:49:40+00:00","article_modified_time":"2026-01-28T12:49:42+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=55712#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=55712"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"China Drug Administration Implementation Regulations Set for May 2026 Launch","datePublished":"2026-01-28T12:49:40+00:00","dateModified":"2026-01-28T12:49:42+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=55712"},"wordCount":578,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["State Council"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=55712#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=55712","url":"https:\/\/flcube.com\/?p=55712","name":"China Drug Administration Implementation Regulations Set for May 2026 Launch - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-01-28T12:49:40+00:00","dateModified":"2026-01-28T12:49:42+00:00","description":"China\u2019s State Council this week issued the Implementation Regulations of the Drug Administration Law, a comprehensive 89\u2011article framework taking effect on May\u202f15\u202f2026. The regulations establish stricter oversight across the drug lifecycle while accelerating pathways for innovation, data protection, and pediatric and rare disease therapies.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=55712#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=55712"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=55712#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"China Drug Administration Implementation Regulations Set for May 2026 Launch"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55712","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=55712"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55712\/revisions"}],"predecessor-version":[{"id":55714,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55712\/revisions\/55714"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=55712"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=55712"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=55712"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}